FDA NDC Directory · JSON-LD · Markdown

Alfuzosin hydrochloride

NDC 76282-302 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerExelan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090284
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsALFUZOSIN HYDROCHLORIDE (10 mg/1)
Marketing started20121002
Package count5

External sources

Source: openFDA. Public-domain (CC0).